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Chapter 9 
Colonising cannabis: Medication, taxation, intoxication and oblivion, c. 
1839-1955. 
James H. Mills 
Introduction 
As the editors of this volume make clear in their introduction, the question ‘what is colonial 
about colonial medicine?’ has stimulated a range of fresh approaches to the issues it raises.  
Among these approaches has been a focus on substances considered to be medical and the 
production of detailed accounts of their histories and the ways in which they came to feature 
in British scientific and medical circles.  After briefly considering the rewards to be had from 
such an approach, this chapter will look at cannabis products and their history in the 
nineteenth and twentieth-centuries.  In part this story is about the entry of preparations of the 
plant into western medical knowledge and practice.  However, the paper also demonstrates 
that cannabis was not simply constructed as a medicine in western circles in this period.  The 
ways in which competing understandings emerged of the plant and the substances that could 
be manufactured from it will also be explored.  The purpose of doing this is two-fold.  In the 
first instance the chapter begins to provide some answers to the question related to the one 
above of ‘what is medical about colonial medicine’?  In addressing this question the chapter 
also addresses its second concern, which is to put the plants back into the picture of the 
history of medicine in the colonial period. 
 




Two recent papers provide fine examples of the benefits of considering the history of 
medicinal substances rather than practitioners, institutions or programmes in colonial South 
Asia.  Markku Hokkanen’s article on Strophanthus kombe shows how an African substance 
became a ‘medicine’ in Western systems during the colonial period.2  Extracts from the plant 
were used in poison arrows in various parts of Africa including Malawi and also featured in 
local medical systems, although the extent to which this was the case could vary 
considerably.  Interest in the nature of the poisons used ensured that British botanical 
explorers in the region worked hard to trace their sources with the help of local chiefs and 
guides.  Once Strophanthus kombe was ‘discovered’ samples were sourced and regularly sent 
back through commercial and missionary networks to Edinburgh University’s laboratories.  
There the important work was done in translating an African substance into a western 
medicine through the medium of experimentation, and eventually the publication of results in 
scientific journals; work which caught the eye of representatives of the British 
pharmaceutical sector.  A market for the substance already existed as its properties were 
thought to make it useful for the treatment of cardiac conditions which were routinely treated 
with digitalis.  As such the Burroughs Wellcome & Company set about funding facilities to 
perfect the process of producing ‘Tincture of Strophanthus’ for commercial purposes.  The 
Company’s marketing campaigns and free samples served to establish its product in the 
Victorian doctor’s medicine chest by 1887.  The paper is an excellent study of the processes 
and actors involved in producing a Western ‘medicine’ from an African plant.  The story 
features African leaders, locals and their knowledge, ‘bio-prospectors’, colonial governments, 
missionary organisations, private companies and university laboratories.  Warfare, 
                                                          
2 M. Hokkanen, Imperial Networks, Colonial Bioprospecting and Burroughs Wellcome & Co.: The Case of 
Strophanthus Kombe from Malawi (1859–1915), Social History of Medicine, 25, 3, 2012, pp. 589-607.  
Additional information on the plant and the colonial history of its extracts can be found in A. Osseo-Asare, 
‘Bioprospecting and Resistance: Transforming Poisoned Arrows into Strophanthin Pills in Colonial Gold Coast, 
1885–1922’, Social History of Medicine 21, 2008, pp. 269-90. 
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diplomacy, exploration, colonialism, investment, experimentation, commercialisation and 
validation by ‘science’ are among the processes that shaped the trajectory.  If those who have 
recently observed that movement and circulation between locales is crucial for the production 
of scientific knowledge are right, then Hokkanen’s paper is a reminder of the importance of 
looking for who and what drives that travel.3 
 
Guy Attewell’s longue durée perspective on tiryaq faruq, a concoction used to treat beri-beri, 
offers other important conclusions.  It shows how British doctors grappling with the condition 
in the 1830s failed to successfully deploy their own medicines and reluctantly turned to the 
local remedy.  They had initially viewed this with some reservation as it was an unfamiliar 
substance recommended by both Muslim and Hindu medical practitioners.  Yet its 
provenance was more complex, as the drug was in fact an import to local medicines, 
delivered by Indian Ocean traders at the end of a journey from Venice where the substance 
had originally been prepared by Jewish physicians using Greek-inspired Arabic medical texts.  
Attewell concludes that ‘Tiryaq meets criteria for being western, colonial, Islamic and Indian 
medicine at the same time- and it therefore highlights the problem with using these very 
terms to describe and analyse complex intercrossings and encounters’.4  In his account the 
history of the mobility of the substance renders unstable any effort to locate it in the 
categories that dominated the historiography until recently, and therefore similarly renders 
those categories unstable. 
                                                          
3 K. Raj, Relocating Modern Science: Circulation and the constitution of scientific knowledge in South Asia and 
Europe, 1650-1900, (Palgrave: Basingstoke, 2007); C. Hayden, When Nature Goes Public: The Making and 
Unmaking of Bioprospecting in Mexico, (Princeton: Princeton University Press, 2003). 
4 G. Attewell, ‘Interweaving Substance Trajectories: Tiryaq, circulation and therapeutic transformation in the 
nineteenth-century’ in A. Digby, W. Ernst and P. Muhkarji (eds), Crossing Colonial Historiographies: Histories 





Cannabis and colonial medicine 
Before the nineteenth-century the cannabis plant and its preparations sometimes featured as 
entries in medical and botanical dictionaries but were little-known or discussed in practice in 
the UK.5  It was not until the nineteenth-century that accounts began to appear in British 
medical circles of preparations of cannabis and it was the efforts of one scientist that lay 
behind their emergence in Victorian medicine in the 1840s.  William Brooke O’Shaughnessy 
was born in Limerick in 1809 and graduated as an MD from Edinburgh University when only 
twenty-one. Just three years later he was on his way to India as an assistant-surgeon.6  On 
arrival in India he eagerly conducted experiments with local drugs and medicines and 
published the results of these in journals such as the Transactions of the Medical and 
Physical Society of Bengal, eventually collecting his conclusions and observations together in 
The Bengal Dispensatory, and Companion to the Pharmacopoeia in 1842 and The Bengal 
Pharmacopeia in 1844.7  In 1842 he also found time to publish A Manual of Chemistry 
arranged for Native, General and Medical Students8 and by then had been made a Professor 
of Chemistry and Medicine in the Medical College of Calcutta.   
 
                                                          
5 J. Mills, Cannabis Britannica: Empire, trade and prohibition, c. 1800-1928, (Oxford: Oxford University Press, 
2003), pp. 17-39. 
6 India Office Library L/Mil/9/383/124 Assistant Surgeon’s Papers 
7 W. O’Shaughnessy, The Bengal Dispensatory and Companion to the Pharmacopoeia, (London: Allen, 1842); 
The Bengal Pharmacopoeia and General Conspectus of Medicinal Plants, (Calcutta: Bishops College Press, 
1844). 
8 W. O’Shaughnessy, A Manual of Chemistry arranged for native, general and medical students and the 
subordinate medical department of the service, (Ostell and Lepage: Calcutta, 1842). 
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His entry on cannabis in the Bengal Dispensatory and Companion to the Pharmacopoeia 
spanned twenty-five pages and had already been partially published as 'On the Preparations 
of the Indian Hemp or Gunjah (Cannabis Indica)' in the Transactions of the Medical and 
Physical Society of Bengal of 1839.  What set his work apart from the entries on cannabis in 
earlier medical and botanical dictionaries was the evidence provided from O’Shaughnessy’s 
close personal work with the substance.  He was careful to refer to the ‘several experiments 
which we have instituted on animals, with the view to ascertain its effects on the healthy 
system; and lastly, we submit an abstract of the clinical details of the treatment of several 
patients afflicted … in which a preparation of hemp was employed’.  His first test subject was 
a ‘middling sized dog’ that ‘became stupid and sleepy’ for six hours on being fed a cannabis 
sample.  Further experiments revealed that ‘while carnivorous animals and fish, dogs, cats, 
swine, vultures, crows and adjutants, invariably and speedily exhibited the intoxicating 
influence of the drug, the graminivorous, such as the horse, deer, monkey, goat, sheep and 
cow experienced but trivial effects from any dose we administered’.   
 
Human trials were hastily arranged as a result of these animal experiments.  One patient who 
was suffering from severe rheumatism was given a cannabis substance and became ‘very 
talkative, … singing songs, calling loudly for an extra supply of food, and declaring himself 
in perfect health’.  Once awake, the patient declared himself to be much improved and he was 
discharged three days later and O’Shaughnessy concluded that the substance had been an 
effective sedative and painkiller.  A case of rabies was treated with cannabis and while it did 
not cure the disease, it allowed the patient constant relief from the horrendous hydrophobia of 
the condition to the extent that he could drink water, eat fruit and swallow rice.  
O’Shaughnessy included this example in his account of the drug as he was impressed by the 
power of hemp to alleviate the hydrophobia. Cannabis tincture was also administered to 
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cholera victims and it seemed to have the effect of controlling diarrhoea and vomiting and of 
inducing rest.  A case of ‘infantile convulsions’ was similarly treated, and although the child 
was at one point ‘in a sinking state’ it survived not only the illness but a range of treatments 
that included ‘two leeches … to the head’, ‘a few doses of calomel and chalk’ and a mouthful 
of opiates.  O’Shaughnessy also reported that considerable improvement could be effected in 
cases of delirium tremens through the administration of cannabis preparations.  
 
O’Shaughnessy’s conclusions were clear.  He recorded in his 1839 paper that 'the results 
seem to me to warrant our anticipating from its more extensive and impartial use no 
inconsiderable addition to the resources of the physician'.  Indeed, in his subsequent guide to 
the Bengal Pharmacopoeia of 1844 he described it as a ‘powerful and valuable remedy in 
hydrophobia, tetanus, cholera and many convulsive disorders’9 and as ‘narcotic, stimulant 
and anti-convulsive, given in cholera, delirium tremens, tetanus and other convulsive 
diseases, also in neuralgia, in tic doloroux etc’.  He outlined the treatment to be used and 
advocated twenty minims and upwards, administered in syrup.  He even helpfully included 
the recipe for the tincture of hemp ‘ganja tops two pounds, rectified spirit one gallon.  
Macerate for two days, then boil for twenty minutes in a distilling apparatus, strain while 
hot’.10 
 
O’Shaughnessy looms so large in the story of the introduction of cannabis substances into 
Victorian medicine as he took on so many of the roles in it.  In Hokkanen’s account of 
                                                          
9 O’Shaughnessy, The Bengal Pharmacopoeia, p. 91. 
10 Ibid., p. 428. 
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Strophanthin different individuals and institutions acted in various capacities.  John Kirk was 
the ‘bio-prospector’ who sought out the plant and liaised with locals about its identity and 
potential and he was in Malawi as a member of David Livingstone’s Zambezi expedition.  It 
was John Buchanan, a former missionary and settler there who began to supply it to the UK, 
and Thomas Fraser, Professor of Materia Medica at Edinburgh University, who used these 
supplies to conduct experiments.  On delivering his conclusions from these experiments in an 
academic paper to the annual meeting of the British Medical Association in 1885 Fraser 
inspired Burroughs Wellcome & Co. to see the potential for profit in the concoction and to 
seek to develop it for commercial purposes.   
 
By contrast, O’Shaughnessy does not appear to have been a man given to delegation. That he 
took on the task of working with locals to establish the uses of cannabis preparations was 
obvious in his acknowledgements, as he thanked both Muslim and Hindu acquaintances for 
their help in providing information.  Syed Keramut Ali was a trustee of the local Imambarrah 
and Hakim Mirza Abdul Rhazes was credited as coming from Teheran and providing 
O’Shaughnessy with information on cannabis in the countries between the Indus and Herat. 
Modoosudun Goopto came from a family of Ayurvedic practitioners and he studied at the 
Sanskrit College in Calcutta before teaching at the British Medical College,11 while 
Kamalakantha Vidyadanka was identified by O’Shaughnessy as ‘celebrated Pundit of the 
Asiatic Society’.  Not that all of his contacts were elite scholars or practitioners, as he was 
careful to note when outlining a particular method of preparing cannabis that ‘the process has 
been repeatedly performed before me by Ameer, the proprietor of a celebrated place of resort 
                                                          
11 D. Bose, ‘Madhusudan Gupta’, Indian Journal of the History of Science, 29, 1, 1994, pp. 31-40. 
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for Hemp devotees in Calcutta, and who is considered the best artist in his profession’.12  If 
he was the ‘bio-prospector’ in the story then he also took on the task of translating this local 
substance into a western medicine through the process of experimentation and publication in 
scientific media.  While his earliest work appeared in books and journals published in India 
the Provincial Medical and Surgical Journal back in the UK was quick to pick up on it.  In 
1843 it devoted the front page of two consecutive editions to updated versions of 
O’Shaughnessy’s earlier papers13 and published an additional letter from him recommending 
cannabis for its ‘extraordinary anticonvulsive power’.14  Indeed, it was O’Shaughnessy who 
took on the job of promoting the drug to British audiences, as he was invited to present to the 
Royal Medico-Botanical Society for which ‘the meeting room of the society was exceedingly 
crowded throughout the evening, the gentlemen present manifesting the most lively interest 
in the discussion’.  His paper went down well and he was presented with the diploma of a 
corresponding member of the society.15  Finally, it was O’Shaughnessy who was behind the 
commercialisation of the substance as he supplied Peter Squire, a pharmacist on Oxford 
Street in London, with a sample from which was produced a tincture that was marketed as 
Squire’s Extract.16  If Hokkanen’s account of Strophanthin is one of a drug’s trajectory 
through professional and commercial networks, this glimpse of the route for cannabis from 
                                                          
12 W. O’Shaughnessy, ‘On the preparations of the Indian hemp, or Gunjah’ in Transactions of the Medical and 
Physical Society of Bengal, 1838-1840, pp. 421-461. 
13 Provincial Medical and Surgical Journal 5, 1842-3, pp. 343-363. 
14 Ibid., p. 397. 
15 ‘Royal Medico-Botanical Society February 22 1843’ in Provincial Medical and Surgical Journal 5, 1842-3, 
pp. 436-438. 
16 M. Booth, Cannabis: A history, (Doubleday: London, 2003), p. 138. 
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Asian substance to western medicine adds the picture of the determined entrepreneur who 
drives it through such professional and commercial networks.17 
 
Once established as a remedy available to Victorian doctors cannabis went on to enjoy a 
modest career in British medicine from the 1840s until the 1890s.18  O’Shaughnessy lost 
interest in it once he secured more profitable work and the difficulties in isolating the active 
ingredient in order to produce standardised medicines from cannabis meant that tinctures 
prepared from it remained unpredictable in practice.  But to leave the story here would be to 
only tell part of it.  While O’Shaughnessy and his contacts in Calcutta and London succeeded 
in deploying the processes and language of contemporary science to establish value for 
cannabis as a medicine, other British doctors used similar techniques to create for the plant 
and its preparations a reputation as a dangerous intoxicant.   
 
Throughout the nineteenth century the British set up a network of lunatic asylums across 
colonial India.  At first these had been established to separate out Indian soldiers that had gone 
mad from the rest of the regiment, and later on the British found that they were useful places 
in which to place those that they found dangerous and disruptive in the local population.  As 
the colonial superintendents at these asylums kept increasingly detailed records of their charges 
                                                          
17 I have argued elsewhere that O’Shaughnessy’s personal circumstances and life-story suggest that he always 
had one eye on personal advancement and his income.  From an Irish Catholic landed family on hard times, he 
sought employment in the East India Company after his father’s death.  He rose rapidly through the ranks, and 
while his interest in cannabis flared early in the 1840s, he soon abandoned it when he secured lucrative posts at 
the Calcutta Mint and eventually as Superintendent of Electric Telegraphs in 1853. …, ‘Irishman, Scottish 
Doctor, British Knight: The career of William O'Shaughnessy of Curragh, 1808-1889’, unpublished paper at 
Ireland, India and Education:  Colonial Connections conference, Trinity College Dublin, October 2008. 
18 See Mills (2003), pp. 49-81; S. Snelders, C. Kaplan and T. Pieters, ‘On Cannabis, Chloral Hydrate, and 
Career Cycles of Psychotropic Drugs in Medicine’, Bulletin of the History of Medicine 80, 1, 2006, 95-114. 
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and began to collate these into statistical tables in end of year reports for their superiors, an 
alarming conclusion began to emerge.  The preponderance of hemp narcotics in the statistical 
table on causes of mental illness among inpatients was regularly commented upon in the 
statements of those in charge of the hospitals.  For example, the superintendent of the Dullunda 
Asylum near Calcutta commented in 1867 that 
 
among the causes of admissions, there appear nothing of novelty or special interest. 
The fact which each succeeding year brings prominently forward, of the prevalence 
of ganja smoking as a fertile source of insanity, is as prominent as ever in the records 
of 1867.19 
 
Similarly, in 1871 Surgeon Cutcliffe pointed out in his report on the asylum at Dacca that 'Table 
no. 4 shows the causes to which the insanity of the patients has been attributed. 33 percent of 
all the cases are attributed to gunja smoking and 7.18 to spirit drinking'.20 In 1875 the officer 
in charge of the asylum in Cuttack pointed out that 'Ganja is reputed as the cause of the majority 
of the admissions and nearly half of the admissions during the past ten years into this asylum 
are attributed to its abuse'.21 Throughout the 1860s and into the 1870s the statistical evidence 
emerging from India’s mental hospitals pointed to the conclusion that the largest single cause 
of the problems experienced by their patients was cannabis use.22   
 
                                                          
19Asylums in Bengal for the Year 1867, (Thacker and Spink: Calcutta, 1868), p. 10. 
20Asylums in Bengal for the Year 1870, (Thacker and Spink: Calcutta, 1868), p. 35. 
21Asylums in Bengal for the Year 1875, (Thacker and Spink: Calcutta, 1868), p. 24. 
22 For more on this network and for the details of the argument of this section see ... 
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By 1871 these statistics had alarmed the Government of India (GOI).  The colonial 
administration ordered an enquiry into cannabis use in its south Asian empire with the 
following remit. 
 
It has been frequently alleged that the abuse of ganja produces insanity and other 
dangerous effects.  
 
The information available in support of these allegations is avowedly imperfect, 
and it does not appear that the attention of the officers in charge of lunatic asylums 
has been systematically directed to ascertain the extent to which the use of the drug 
produces insanity. 
 
But as it is desirable to make a complete and careful enquiry into the matter, the 
Governor-General in Council requests that Madras, Bombay etc. will be so good as to 
cause such investigations as are feasible to be carried out in regard to the effects of the 
use or abuse of the several preparations of hemp.23 
 
In 1873 the Resolution of the GOI at the end of the inquiry stated of cannabis that ‘There can 
… be no doubt that its habitual use does tend to produce insanity’.24  The administration was 
so confident of this assertion about the link between use of hemp substances and mental illness 
because it had been persuaded by the numbers.  In its Resolution, figures were produced from 
                                                          
23‘Papers relating to the consumption of ganja and other drugs in India’, in British Parliamentary Papers, volume 
66, (Hansard: London 1891), pp. 7-8. 
24 Ibid., p. 92. 
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asylums in the Central Provinces, Mysore, the Punjab and Bengal and a statistical table from 
the Delhi institution was reproduced as was its superintendent’s observation that: 
 
Of 317 lunatics received into the Nagpur Asylum since 1864, there were 61 in 
whom insanity had been occasioned by an immoderate use of ganja ... From this 
result it is inferred that excess in ganja-smoking does produce an insanity which is 
transient.25 
 
The colonial officials in the Government of India had been convinced by the science of the 
statistic.  It acted upon its conclusion by prohibiting the cultivation and consumption of ganja 
in Burma and urging other parts of British India to 'discourage the consumption of ganja and 
bhang by placing restrictions on their cultivation, preparation and retail, and imposing on 
their use as high a rate of duty as can be levied without inducing illicit practices'.26   
 
It has been argued that these statistics were deeply flawed, as they were shaped by cultural 
misunderstandings, bureaucratic shortcomings and the assumptions of the psychiatry of the 
period.27  However, these flaws were deemed unimportant at the time because statistical data 
was highly regarded in colonial India.  It lent authority to the efforts of colonisers in 
comprehending and managing a context that they often found bewilderingly complex.28  In 
                                                          
25Ibid., p. 88.  
26Ibid., p. 92. 
27 Mills (2000). 
28 This argument draws on A. Appadurai, 'Number in the Colonial Imagination', in C.A.Breckenridge and Peter 
van der Veer (eds.), Orientalism and the Postcolonial Predicament: Perspectives on South Asia (Philadelphia: 
University of Pennsylvania Press, 1993); and B. Cohn, ‘The census, social structure and objectification in South 
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this case the statistical data acted much as the experiments had in the tale told in Hokkanen’s 
paper and in the story of O’Shaughnessy above.29  They rendered impressions formed in 
south Asia into scientific conclusions for circulation amongst westerners.  But, in this case, 
the production of scientific data on cannabis consumption gave rise to a conclusion that 
challenged existing understandings and practices. In the 1860s, ideas about the dangers of 
using preparations of the plant emerged that countered therapeutic assessments of the 
substance. 
 
Cannabis and the anti-opium campaigners 
 
Yet cannabis was also given further meanings elsewhere in colonial networks that linked 
south Asia and Britain.  The GOI had first shown an interest in the substance not as a 
medicine or as a cause of disease but as a commodity.  Preparations of the plant had been 
commercially traded across south Asia long before the arrival of the British and the cultivated 
form was prized as the key ingredient in a range of intoxicating products.30   As early as 1793 
East India Company officials at the Bengal Board of Revenue had recognised this and sought 
to derive income from the trade by including cannabis products in their lists of excise items to 
be subjected to government duties.  The system that they devised demanded that the retailer 
of the drug, before approaching the peasant producers, had to turn up at the office of the local 
                                                          
Asia’ in B. Cohn, An Anthropologist among the Historians and Other Essays, (Oxford University Press: Delhi, 
1987). 
29 For more on the competing types of evidence that were established as valid for scientific enquiry see J. 
Pickstone, Ways of Knowing: A new history of science, technology and medicine, (Manchester University Press: 
Manchester, 2000), pp. 135-161.  
30 For more on uses for cannabis products in south Asia in this period see Mills (2003), pp. 47-51. 
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colonial official and pay for a licence that would grant him permission to proceed and buy his 
stock of the drugs. Having done this, he was free to head on to meet his supplier and to 
purchase as much as wanted after which he was equally free to go and sell it wherever he 
wanted. In other words, the government was simply concerned to guarantee that the licenses 
were bought and they cared little about how much of the drugs were being produced or 
consumed.30  It was decided by the middle of the century that there was more money to be 
had from the trade as the scheme was changed in 1854 to tax the wholesaler in his place of 
business rather than at the point of purchase or production. In other words once the stock of 
ganja was in the wholesaler's warehouse the district collector there would be able to assess 
his approximate holdings and to maintain surveillance of how much the retail buyers were 
taking from the wholesaler. The amount sold by the wholesaler to the retailer was therefore 
taxed. The British gradually realised that the key to the success of levying this duty was an 
accurate knowledge of the amount of ganja in the system. To this end the Board of Revenue 
introduced a series of additional licences in 1876. The peasant producer of the hemp plant 
had to approach the authorities to obtain a licence to cultivate the crop. When the crop was 
ready and the ganja had been processed, the cultivator had to apply for a licence to store the 
drug. To be granted this licence he stated how much of the drug he intended to store and the 
permit was made out to cover this amount. The wholesaler meanwhile needed to apply for a 
permit to collect supplies from the cultivators which stated how much he intended to 
purchase.31  By the 1880s levies on cannabis products were worth almost Rs 200,000 in 
Bengal alone.  This made tax on preparations of the plant in the Presidency a more important 
                                                          
31 This summary of the evolution of the ganja excise system is compiled from Hem Chunder Kerr, ‘Report of 
the Cultivation of and Trade in Ganja in Bengal’ in British Parliamentary Papers, volume 66, (Hansard: 




source of revenue than tax on opium sold in the region.32 
 
Various constructions of cannabis existed by the 1880s: the useful medicine, the cause of 
mental illness, the product on the excise list.  As the 1880s progressed another version 
emerged, one that drew on these previous ideas but which recast them within the political and 
cultural tensions of late Victorian Britain.  Mark Stewart MP stood up in the House of 
Commons on 16 July of that year ‘to ask the Under-Secretary of State for India whether his 
attention has been called to the statement in the Allahabad Pioneer of the 10th May last that 
ganja 'which is grown, sold and excised under much the same conditions as opium', is far 
more harmful than opium, and that 'the lunatic asylums of India are filled with ganja 
smokers'.   He pressed his point, asking further of the Secretary of State ‘whether he is aware 
that the possession and sale of ganja has been prohibited for many years past in Lower Burma 
and that the exclusion of the drug was stated in the Excise Report of that province for 1881-
82 to have been ‘of immense benefit to the people’.  The reason for his curiosity was that he 
wanted to know ‘whether he [the Secretary of State] will call the attention of the Government 
of India to the desirability of extending the same prohibition to the other Provinces of 
India?’33 
 
The figures generated by India’s mental hospitals had finally arrived back in the UK, and the 
conclusion that they had generated, that cannabis was a source of ill-health, had been used in 
Parliament to challenge the idea that it was simply an article of excise.  The multiple 
                                                          
32 G. Watt, Hemp or Cannabis Sativa (being an enlargement of the article in the ‘Dictionary of Economic Products 
of India’), (Calcutta, 1887), p. 21. 
33 Hansard’s Parliamentary Debates, vol. 355 (3rd Series), pp. 1395-1412, 16 July 1891. 
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constructions of cannabis no longer existed apart from one another, but were now in direct 
conflict with one another.  While Stewart initiated the campaign against cannabis it was his 
colleague, William Caine, who took it forwards.  A founder member of the Anglo-Indian 
Temperance Association, he had visited India in 1888 to promote that organisation through the 
missionary networks there.34  Accompanied on his trip by the experienced Baptist missionary, 
Thomas Evans, who had over thirty years of service in India to his name, Caine had his 
attention drawn to cannabis: 
 
Here and there throughout the bazar are little shops whose entire stock consists of a small 
lump of greenish pudding, which is being retailed out in tiny cubes. This is another 
‘Government monopoly’ and is majoon, a preparation of the deadly bhang or Indian 
hemp known in Turkey and Egypt as Haseesh, the most horrible intoxicant the world has 
yet produced. In Egypt, its importation and sale is absolutely forbidden and a costly 
preventive service is maintained to suppress smuggling of it by Greek adventurers; but a 
Christian Government is wiser in its generation and gets a comfortable income out of its 
sale. When an Indian wants to commit some horrible crime, such as murder or wife 
mutilation, he prepares himself for it with two anna’s worth of bhang from a government 
majoon shop. The little rooms, open to the street, of which the sole furniture is some 
matting and a few Hukas, are churras or Chandu shops, farmed out by the government of 
India to provide another form of Indian hemp intoxication which is smoked instead of 
eaten. 35 
 
                                                          
34 J. Mills, ‘Cannabis in the Commons: Colonial Networks, Missionary Politics and the origins of the Indian 
Hemp Drugs Commission 1893-4’, Journal of Colonialism and Colonial History 6, 1, 2005. 
35 W.S. Caine, Picturesque India, A Handbook for European Travellers, (London: Routledge, 1890) 292. 
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Caine and Stewart were not simply veteran temperance campaigners but also active members 
of the anti-opium movement which was gathering pace in the 1890s and which was to lead to 
the Royal Opium Commission of 1895.  They drew on Caine’s networking in India to cast 
existing discourses on cannabis within the ideas that drove these campaigns, in which 
intoxication was self-evidently immoral and those that enabled it were wrong.  Cannabis as a 
source of excise, and cannabis as a source of mental health problems, were rewoven by these 
campaigners to produce the conclusion that cannabis was ‘the most horrible intoxicant the 
world has yet produced’. 
 
By the 1890s cannabis had multiple meanings in different discursive systems.  In the medical 
world there were those that saw its positive values, and there was a revival of interest in British 
pharmacology towards the end of that decade in isolating its active ingredient.  However, there 
were also those that saw it as a cause of mental health problems and, despite detailed 
investigation into the reliability of the statistics from Indian asylums in the 1890s, that data 
continued to stimulate debate into the twentieth-century.  For those at the Board of Revenue in 
Bengal cannabis was simply a source of revenue to be managed and augmented.  For the anti-
opium campaigners it had a deliciously negative value in their moral system, its consumption 
for intoxication making it an evil and the GOI’s revenue from it providing evidence of its failure 
to live by high standards.  Such was the force of the recasting of cannabis as a moral issue that 
the GOI was compelled to appoint the Indian Hemp Drugs Commission (IHDC) in 1893 to 
investigate it.  The task of the IHDC was to test the various discursive representations and to 
see how far they could be reconciled.  It opted to privilege the version of cannabis that held it 
to be the source of useful medicines, and to destabilise the notion that it was a dangerous 
intoxicant by promoting the idea that it was a harmless one.  The IHDC stood accused by its 
critics of really seeking to privilege the discourse that simply saw cannabis as a lucrative excise 
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The conclusions to be drawn from these stories for the purposes of this volume are various.  
Much good work has been done recently to respond to the question ‘what is colonial about 
colonial medicine?’ and if this chapter sheds light in that direction it is in order to draw 
further attention to the unstable nature of the ‘colonial’ in the question.  After all, in the 
stories the ‘colonial’ is fractured and incoherent, with western doctors using different 
methodologies and samples to reach conflicting conclusions about the nature of preparations 
of the plant, British administrators framing the drug simply as an excise item to be carefully 
managed to maximise revenues, and Victorian moralists condemning cannabis substances as 
perilous intoxicants.  Hokkanen’s paper on Strophanthus is an excellent account of the way 
that an African plant acquired technical meaning as it travelled along the scientific network 
that linked Malawi and Britain.  This paper has shown how an Asian plant similarly travelled 
along the scientific network that linked the Empire with the UK, but that it did this in 
multiple ways, and at the same time was propelled along some of the many other networks 
linking south Asia with Britain in this period.  
 
The editors of this volume are right that ‘medicine [is] an important organizing concept, 
which is historically produced, and yet shapes discourses, practices, and subjectivities’ but 
this chapter suggest that it is only one such organising system in this period and that as 
                                                          
36 For more on attitudes towards cannabis in the 1890s and the origins and outcomes of the Indian Hemp Drugs 
Commission see Mills (2003), pp. 93-151. 
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cannabis travelled along the various networks mentioned above it acquired multiple 
meanings.  The outcome was that the  status of cannabis as a therapeutic substance in this 
context was a contested one, so the eye is therefore drawn to the question of ‘what is 
‘medical’ about colonial medicine?’  The account given here of cannabis shows how difficult 
it is to fix that plant and its preparations in a medical system at all.  Its history since the 
British arrived in south Asia has been one where efforts to establish cannabis as a medicine 
were constantly contested by its other associations and meanings attached to it outside of 
medical circles.  Indeed, this chapter has not had the space to dwell on a further set of 
meanings established for cannabis once news of it arrived back in Britain, where at various 
times it was recast as an exotic source of delightful oblivion or even ‘astral travel’ in literary 
and occultist circles.37  It seems that cannabis was sometimes, and in some places, a 
medicine, but that often it was not seen as medical at all, but rather it was viewed as a moral 
concern, an excise problem, or even a spiritual opportunity.  The story of cannabis and the 
various ways in which it was imagined as it was encountered in colonial India and made its 
way to Britain points to the instability of the notion of ‘medicine’, and how historically 
contingent the award of that label can be. 
 
While the chapter has traced the competing agendas and systems of meaning that framed 
cannabis and produced so many different versions of it in British culture, it has not fully 
addressed a final reason that cannabis was imagined or constructed in so many different 
ways.  It seems important to consider the plant itself in trying to explain why cannabis has not 
been fixed in any one particular discursive context or by any one agenda, be it scientific, 
                                                          
37 See Mills (2003), pp. 149-151; V. Berridge, ‘The origins of the English drug "scene" 1890-1930’, Medical 
History, 32, 1, 1988, pp. 51–64. 
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economic or moral.  Cannabis is a bewilderingly complex plant, with over a hundred active 
ingredients, which have multiple effects (only some of which are psychoactive) on human 
bodies, which are mediated by individual constitutions.38  One of the key reasons, perhaps the 
most significant of them, that cannabis has defied efforts to lodge it within moral, medical or 
economic systems of meaning is the plant itself as its complicated nature defies 
generalisation and easy categorisation.  In this case at least, a ‘biological turn’ seems 
important in understanding why a set of plant substances first encountered by the British in a 
colonial context has enjoyed such an unstable and contested career as a medicine.  It will be 
interesting to see if such a ‘biological turn’ is of wider use to those seeking to rethink the 
nature of the notion of the ‘medical’. 
 
                                                          
38 R. Pertwee, ‘The pharmacology of cannabis: new discoveries and therapeutic possibilities’, unpublished paper 
at The Royal College of Psychiatrists in Scotland Addictions Faculty Annual Residential Meeting 2012. 
